HeadlinesBriefing favicon HeadlinesBriefing.com

US Treasury Doubles Bond Buybacks, Moderna Vaccine Trial Success

Financial Times Markets •
×

The US Treasury announced it will at least double the size of its buyback of long-term government debt, aiming to soothe a jittery bond market. This move comes as financial markets react to various global economic pressures affecting sovereign debt valuations.

Meanwhile, shares in vaccine-maker Moderna surged after the company reported successful trial results for an experimental cancer vaccine targeting melanoma. The positive clinical data has boosted investor confidence in the biotech sector, with Moderna stock experiencing significant gains.

In other news, top US legal firms face growing controversy over their hiring practices, with backlash mounting against the recruitment of students in their first few months of law school. Critics argue these early hiring decisions create unfair advantages and disrupt the traditional legal career pipeline.

Additionally, Irish pubs continue to disappear from communities, raising concerns about the preservation of cultural heritage and local businesses. These closures reflect broader economic challenges facing the hospitality industry.